# A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood

> **NCT07133399** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 32 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** vicadrostat / empagliflozin combination 1
- **DRUG:** vicadrostat / empagliflozin 2

## Key facts

- **NCT ID:** NCT07133399
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-09-08
- **Primary completion:** 2025-10-22
- **Final completion:** 2025-10-22
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07133399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07133399, "A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Blood". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07133399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*